0001104659-20-085611.txt : 20200722 0001104659-20-085611.hdr.sgml : 20200722 20200722160252 ACCESSION NUMBER: 0001104659-20-085611 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200720 FILED AS OF DATE: 20200722 DATE AS OF CHANGE: 20200722 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Necina Roman CENTRAL INDEX KEY: 0001794381 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38869 FILM NUMBER: 201041543 MAIL ADDRESS: STREET 1: C/O HOOKIPA PHARMA INC. STREET 2: 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 CITY: NEW YORK STATE: NY ZIP: 10118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HOOKIPA Pharma Inc. CENTRAL INDEX KEY: 0001760542 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 815395687 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 0114318906360 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 4 1 a4.xml 4 X0306 4 2020-07-20 0 0001760542 HOOKIPA Pharma Inc. HOOK 0001794381 Necina Roman C/O HOOKIPA PHARMA INC., 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118 0 1 0 0 Chief Technology Officer Common Stock 2020-07-20 4 A 0 1984 0 A 1984 D The Reporting Person was awarded 1,984 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of HOOKIPA Pharma Inc.'s Common Stock. The restricted stock units vest shall vest in four equal installments on March 20, 2021, May 15, 2021, August 15, 2021 and November 15, 2021. The restricted stock units may be settled only by delivering shares of HOOKIPA Pharma Inc.'s Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. /s/ Reinhard Kandera, as Attorney-in-Fact 2020-07-22